Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
17/05/2024 | 22:10 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] | NASDAQ:BNTX | BioNTech SE |
17/05/2024 | 17:15 | GlobeNewswire Inc. | BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 | NASDAQ:BNTX | BioNTech SE |
06/05/2024 | 14:09 | IH Market News | Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise | NASDAQ:BNTX | BioNTech SE |
06/05/2024 | 12:45 | GlobeNewswire Inc. | BioNTech Announces First Quarter 2024 Financial Results and Corporate Update | NASDAQ:BNTX | BioNTech SE |
26/04/2024 | 13:48 | IH Market News | Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News | NASDAQ:BNTX | BioNTech SE |
24/04/2024 | 13:28 | IH Market News | Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News | NASDAQ:BNTX | BioNTech SE |
22/04/2024 | 12:45 | GlobeNewswire Inc. | BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 | NASDAQ:BNTX | BioNTech SE |
07/04/2024 | 20:00 | GlobeNewswire Inc. | Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer | NASDAQ:BNTX | BioNTech SE |
21/03/2024 | 12:17 | IH Market News | Apple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market Updates | NASDAQ:BNTX | BioNTech SE |
20/03/2024 | 12:17 | IH Market News | U.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices Dip | NASDAQ:BNTX | BioNTech SE |
20/03/2024 | 11:15 | GlobeNewswire Inc. | BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update | NASDAQ:BNTX | BioNTech SE |
20/03/2024 | 11:00 | GlobeNewswire Inc. | BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer | NASDAQ:BNTX | BioNTech SE |
11/03/2024 | 12:45 | GlobeNewswire Inc. | BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024 | NASDAQ:BNTX | BioNTech SE |
11/03/2024 | 11:25 | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTX | NASDAQ:BNTX | BioNTech SE |
07/03/2024 | 12:45 | GlobeNewswire Inc. | BioNTech Announces Planned Retirement of Sean Marett | NASDAQ:BNTX | BioNTech SE |
06/03/2024 | 12:45 | GlobeNewswire Inc. | BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024 | NASDAQ:BNTX | BioNTech SE |
05/03/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX | NASDAQ:BNTX | BioNTech SE |
29/02/2024 | 00:26 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:BNTX | BioNTech SE |
26/02/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More | NASDAQ:BNTX | BioNTech SE |
22/02/2024 | 11:45 | PR Newswire (US) | BioNTech SE Sued for Securities Law Violations - Contact The Gross Law Firm Before March 12, 2024 to Discuss Your Rights - BNTX | NASDAQ:BNTX | BioNTech SE |
15/02/2024 | 22:10 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:BNTX | BioNTech SE |
14/02/2024 | 13:26 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:BNTX | BioNTech SE |
09/02/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) Shareholders | NASDAQ:BNTX | BioNTech SE |
08/02/2024 | 11:45 | GlobeNewswire Inc. | BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs | NASDAQ:BNTX | BioNTech SE |
08/02/2024 | 11:45 | GlobeNewswire Inc. | BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs | NASDAQ:BNTX | BioNTech SE |
02/02/2024 | 11:45 | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioNTech SE of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2024 - (NASDAQ: BNTX) | NASDAQ:BNTX | BioNTech SE |
31/01/2024 | 12:45 | GlobeNewswire Inc. | BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305 | NASDAQ:BNTX | BioNTech SE |
22/01/2024 | 12:45 | GlobeNewswire Inc. | BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer | NASDAQ:BNTX | BioNTech SE |
10/01/2024 | 12:21 | IH Market News | Wall Street Highlights: Tesla Launches Restyled Model 3, VinFast Unveils Pickup Prototype, and More | NASDAQ:BNTX | BioNTech SE |
09/01/2024 | 20:57 | Dow Jones News | BioNTech Shares Down 3.4%; Sees 2024 Revenue Below Wall Street Views | NASDAQ:BNTX | BioNTech SE |